nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminosalicylic Acid—MPO—Calcipotriol—psoriasis	0.541	0.803	CbGbCtD
Aminosalicylic Acid—PTGS2—Triamcinolone—psoriasis	0.0564	0.0836	CbGbCtD
Aminosalicylic Acid—PTGS2—Betamethasone—psoriasis	0.0484	0.0717	CbGbCtD
Aminosalicylic Acid—PTGS2—Dexamethasone—psoriasis	0.0281	0.0417	CbGbCtD
Aminosalicylic Acid—PTGS2—skeletal joint—psoriasis	0.00279	0.188	CbGeAlD
Aminosalicylic Acid—MPO—endothelium—psoriasis	0.00218	0.146	CbGeAlD
Aminosalicylic Acid—PTGS2—synovial membrane of synovial joint—psoriasis	0.00212	0.143	CbGeAlD
Aminosalicylic Acid—CHUK—skin of body—psoriasis	0.00195	0.131	CbGeAlD
Aminosalicylic Acid—PTGS2—skin epidermis—psoriasis	0.00136	0.0915	CbGeAlD
Aminosalicylic Acid—PTGS1—endothelium—psoriasis	0.00103	0.0695	CbGeAlD
Aminosalicylic Acid—PTGS2—endothelium—psoriasis	0.000987	0.0664	CbGeAlD
Aminosalicylic Acid—MPO—skin of body—psoriasis	0.00093	0.0625	CbGeAlD
Aminosalicylic Acid—Mesalazine—PPARG—psoriasis	0.000908	1	CrCbGaD
Aminosalicylic Acid—PTGS2—Fluocinonide—Clobetasol propionate—psoriasis	0.000858	0.157	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Beclomethasone—psoriasis	0.000687	0.126	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Fluocinolone Acetonide—psoriasis	0.000668	0.122	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Clobetasol propionate—psoriasis	0.000518	0.0948	CbGdCrCtD
Aminosalicylic Acid—PTGS1—skin of body—psoriasis	0.000441	0.0297	CbGeAlD
Aminosalicylic Acid—PTGS2—skin of body—psoriasis	0.000422	0.0283	CbGeAlD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Fluocinonide—psoriasis	0.000415	0.076	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Beclomethasone—psoriasis	0.000415	0.076	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—psoriasis	0.000403	0.0738	CbGdCrCtD
Aminosalicylic Acid—Rash—Methoxsalen—psoriasis	0.000344	0.00211	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Methoxsalen—psoriasis	0.000344	0.00211	CcSEcCtD
Aminosalicylic Acid—Urticaria—Acitretin—psoriasis	0.000344	0.00211	CcSEcCtD
Aminosalicylic Acid—Flatulence—Mycophenolic acid—psoriasis	0.000343	0.00211	CcSEcCtD
Aminosalicylic Acid—Jaundice—Mycophenolate mofetil—psoriasis	0.000343	0.0021	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Acitretin—psoriasis	0.000342	0.0021	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Acitretin—psoriasis	0.000342	0.0021	CcSEcCtD
Aminosalicylic Acid—Headache—Methoxsalen—psoriasis	0.000342	0.0021	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Fluocinolone Acetonide—psoriasis	0.000341	0.00209	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Triamcinolone—psoriasis	0.000341	0.00209	CcSEcCtD
Aminosalicylic Acid—PTGS1—tendon—psoriasis	0.000336	0.0226	CbGeAlD
Aminosalicylic Acid—Nervous system disorder—Hydroxyurea—psoriasis	0.000333	0.00204	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Calcitriol—psoriasis	0.000333	0.00204	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Hydroxyurea—psoriasis	0.000333	0.00204	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Hydroxyurea—psoriasis	0.00033	0.00202	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Mycophenolate mofetil—psoriasis	0.000328	0.00201	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Hydrocortisone—psoriasis	0.000325	0.002	CcSEcCtD
Aminosalicylic Acid—Nausea—Methoxsalen—psoriasis	0.000324	0.00199	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Cyclosporine—psoriasis	0.000324	0.00199	CcSEcCtD
Aminosalicylic Acid—Anorexia—Hydroxyurea—psoriasis	0.000324	0.00199	CcSEcCtD
Aminosalicylic Acid—Anaemia—Mycophenolic acid—psoriasis	0.000322	0.00198	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisolone—psoriasis	0.000322	0.00197	CcSEcCtD
Aminosalicylic Acid—Purpura—Prednisone—psoriasis	0.000321	0.00197	CcSEcCtD
Aminosalicylic Acid—PTGS2—tendon—psoriasis	0.000321	0.0216	CbGeAlD
Aminosalicylic Acid—Urinary tract disorder—Cyclosporine—psoriasis	0.00032	0.00196	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Acitretin—psoriasis	0.000319	0.00195	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.000318	0.00195	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Cyclosporine—psoriasis	0.000318	0.00195	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Mycophenolate mofetil—psoriasis	0.000316	0.00194	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Hydrocortisone—psoriasis	0.000314	0.00193	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Dexamethasone—psoriasis	0.000313	0.0574	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Betamethasone—psoriasis	0.000313	0.0574	CbGdCrCtD
Aminosalicylic Acid—Urinary tract disorder—Mycophenolate mofetil—psoriasis	0.000312	0.00191	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mycophenolic acid—psoriasis	0.000312	0.00191	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Mycophenolate mofetil—psoriasis	0.00031	0.0019	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal haemorrhage—Prednisone—psoriasis	0.00031	0.0019	CcSEcCtD
Aminosalicylic Acid—Vomiting—Calcitriol—psoriasis	0.000309	0.0019	CcSEcCtD
Aminosalicylic Acid—Rash—Calcitriol—psoriasis	0.000307	0.00188	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Calcitriol—psoriasis	0.000306	0.00188	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluocinonide—Triamcinolone—psoriasis	0.000306	0.0561	CbGdCrCtD
Aminosalicylic Acid—Headache—Calcitriol—psoriasis	0.000305	0.00187	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Acitretin—psoriasis	0.000296	0.00182	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Triamcinolone—psoriasis	0.000296	0.00182	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Hydroxyurea—psoriasis	0.000295	0.00181	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000295	0.00181	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—psoriasis	0.000295	0.00181	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000293	0.0018	CcSEcCtD
Aminosalicylic Acid—Nausea—Calcitriol—psoriasis	0.000289	0.00177	CcSEcCtD
Aminosalicylic Acid—Dizziness—Acitretin—psoriasis	0.000286	0.00175	CcSEcCtD
Aminosalicylic Acid—Dizziness—Fluocinolone Acetonide—psoriasis	0.000285	0.00175	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Cyclosporine—psoriasis	0.000282	0.00173	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Mycophenolic acid—psoriasis	0.000279	0.00171	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mycophenolic acid—psoriasis	0.000279	0.00171	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Betamethasone—psoriasis	0.000278	0.00171	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Dexamethasone—psoriasis	0.000278	0.00171	CcSEcCtD
Aminosalicylic Acid—Flatulence—Cyclosporine—psoriasis	0.000278	0.0017	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mycophenolic acid—psoriasis	0.000276	0.00169	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Cyclosporine—psoriasis	0.000276	0.00169	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Mycophenolate mofetil—psoriasis	0.000275	0.00169	CcSEcCtD
Aminosalicylic Acid—Vomiting—Acitretin—psoriasis	0.000275	0.00169	CcSEcCtD
Aminosalicylic Acid—Vomiting—Fluocinolone Acetonide—psoriasis	0.000274	0.00168	CcSEcCtD
Aminosalicylic Acid—Dermatitis exfoliative—Methotrexate—psoriasis	0.000274	0.00168	CcSEcCtD
Aminosalicylic Acid—Rash—Acitretin—psoriasis	0.000273	0.00167	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Acitretin—psoriasis	0.000273	0.00167	CcSEcCtD
Aminosalicylic Acid—Rash—Fluocinolone Acetonide—psoriasis	0.000272	0.00167	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Fluocinolone Acetonide—psoriasis	0.000272	0.00167	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mycophenolic acid—psoriasis	0.000271	0.00166	CcSEcCtD
Aminosalicylic Acid—Flatulence—Mycophenolate mofetil—psoriasis	0.000271	0.00166	CcSEcCtD
Aminosalicylic Acid—Headache—Acitretin—psoriasis	0.000271	0.00166	CcSEcCtD
Aminosalicylic Acid—Headache—Fluocinolone Acetonide—psoriasis	0.00027	0.00166	CcSEcCtD
Aminosalicylic Acid—Abdominal distension—Prednisone—psoriasis	0.000269	0.00165	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Mycophenolate mofetil—psoriasis	0.000269	0.00165	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Betamethasone—psoriasis	0.000269	0.00165	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Dexamethasone—psoriasis	0.000269	0.00165	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Hydroxyurea—psoriasis	0.000268	0.00165	CcSEcCtD
Aminosalicylic Acid—Anaemia—Cyclosporine—psoriasis	0.000261	0.0016	CcSEcCtD
Aminosalicylic Acid—Nausea—Acitretin—psoriasis	0.000257	0.00158	CcSEcCtD
Aminosalicylic Acid—Nausea—Fluocinolone Acetonide—psoriasis	0.000256	0.00157	CcSEcCtD
Aminosalicylic Acid—Anaemia—Mycophenolate mofetil—psoriasis	0.000254	0.00156	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Cyclosporine—psoriasis	0.000252	0.00155	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Hydrocortisone—psoriasis	0.000251	0.00154	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Hydroxyurea—psoriasis	0.00025	0.00153	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mycophenolic acid—psoriasis	0.000247	0.00152	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Mycophenolate mofetil—psoriasis	0.000246	0.00151	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000246	0.00151	CcSEcCtD
Aminosalicylic Acid—Weight decreased—Prednisone—psoriasis	0.000242	0.00148	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—psoriasis	0.000238	0.00146	CcSEcCtD
Aminosalicylic Acid—Neuropathy peripheral—Prednisone—psoriasis	0.000234	0.00143	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Mycophenolic acid—psoriasis	0.000233	0.00143	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—psoriasis	0.000233	0.00143	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Hydroxyurea—psoriasis	0.000232	0.00143	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Triamcinolone—psoriasis	0.000231	0.00142	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Cyclosporine—psoriasis	0.000226	0.00138	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Cyclosporine—psoriasis	0.000225	0.00138	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mycophenolic acid—psoriasis	0.000225	0.00138	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mycophenolic acid—psoriasis	0.000225	0.00138	CcSEcCtD
Aminosalicylic Acid—Dizziness—Hydroxyurea—psoriasis	0.000225	0.00138	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Cyclosporine—psoriasis	0.000224	0.00137	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Mycophenolate mofetil—psoriasis	0.00022	0.00135	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Mycophenolate mofetil—psoriasis	0.00022	0.00135	CcSEcCtD
Aminosalicylic Acid—Anorexia—Cyclosporine—psoriasis	0.000219	0.00135	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Mycophenolate mofetil—psoriasis	0.000218	0.00134	CcSEcCtD
Aminosalicylic Acid—Vomiting—Hydroxyurea—psoriasis	0.000216	0.00132	CcSEcCtD
Aminosalicylic Acid—Rash—Hydroxyurea—psoriasis	0.000214	0.00131	CcSEcCtD
Aminosalicylic Acid—Anorexia—Mycophenolate mofetil—psoriasis	0.000214	0.00131	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Hydroxyurea—psoriasis	0.000214	0.00131	CcSEcCtD
Aminosalicylic Acid—Headache—Hydroxyurea—psoriasis	0.000213	0.00131	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000212	0.0013	CcSEcCtD
Aminosalicylic Acid—Nausea—Hydroxyurea—psoriasis	0.000202	0.00124	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Hydrocortisone—psoriasis	0.000201	0.00123	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Cyclosporine—psoriasis	0.0002	0.00123	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000199	0.00122	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Hydrocortisone—psoriasis	0.000199	0.00122	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000195	0.0012	CcSEcCtD
Aminosalicylic Acid—Anorexia—Hydrocortisone—psoriasis	0.000195	0.0012	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mycophenolic acid—psoriasis	0.000195	0.00119	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000194	0.00119	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Betamethasone—psoriasis	0.000189	0.0346	CbGdCrCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Dexamethasone—psoriasis	0.000189	0.0346	CbGdCrCtD
Aminosalicylic Acid—Gastrointestinal pain—Cyclosporine—psoriasis	0.000188	0.00115	CcSEcCtD
Aminosalicylic Acid—Dizziness—Mycophenolic acid—psoriasis	0.000188	0.00115	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Prednisone—psoriasis	0.000186	0.00114	CcSEcCtD
Aminosalicylic Acid—Agranulocytosis—Methotrexate—psoriasis	0.000186	0.00114	CcSEcCtD
Aminosalicylic Acid—PTGS2—Fluticasone Propionate—Triamcinolone—psoriasis	0.000185	0.0338	CbGdCrCtD
Aminosalicylic Acid—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000184	0.00113	CcSEcCtD
Aminosalicylic Acid—Urticaria—Cyclosporine—psoriasis	0.000183	0.00112	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Cyclosporine—psoriasis	0.000182	0.00112	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Cyclosporine—psoriasis	0.000182	0.00112	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mycophenolic acid—psoriasis	0.000181	0.00111	CcSEcCtD
Aminosalicylic Acid—Rash—Mycophenolic acid—psoriasis	0.000179	0.0011	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mycophenolic acid—psoriasis	0.000179	0.0011	CcSEcCtD
Aminosalicylic Acid—Hepatitis—Methotrexate—psoriasis	0.000179	0.0011	CcSEcCtD
Aminosalicylic Acid—Urticaria—Mycophenolate mofetil—psoriasis	0.000178	0.00109	CcSEcCtD
Aminosalicylic Acid—Headache—Mycophenolic acid—psoriasis	0.000178	0.00109	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Hydrocortisone—psoriasis	0.000178	0.00109	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000177	0.00109	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000177	0.00109	CcSEcCtD
Aminosalicylic Acid—Urinary tract disorder—Methotrexate—psoriasis	0.000177	0.00108	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000177	0.00108	CcSEcCtD
Aminosalicylic Acid—Urethral disorder—Methotrexate—psoriasis	0.000175	0.00108	CcSEcCtD
Aminosalicylic Acid—Anaemia—Prednisone—psoriasis	0.000172	0.00106	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Betamethasone—psoriasis	0.000171	0.00105	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Dexamethasone—psoriasis	0.000171	0.00105	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Dexamethasone—psoriasis	0.000171	0.00105	CcSEcCtD
Aminosalicylic Acid—Thrombocytopenia—Betamethasone—psoriasis	0.000171	0.00105	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Cyclosporine—psoriasis	0.00017	0.00104	CcSEcCtD
Aminosalicylic Acid—Nausea—Mycophenolic acid—psoriasis	0.000169	0.00104	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000167	0.00103	CcSEcCtD
Aminosalicylic Acid—Anorexia—Dexamethasone—psoriasis	0.000167	0.00102	CcSEcCtD
Aminosalicylic Acid—Anorexia—Betamethasone—psoriasis	0.000167	0.00102	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisolone—psoriasis	0.000166	0.00102	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000165	0.00101	CcSEcCtD
Aminosalicylic Acid—Urticaria—Hydrocortisone—psoriasis	0.000162	0.000997	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Hydrocortisone—psoriasis	0.000162	0.000992	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Hydrocortisone—psoriasis	0.000162	0.000992	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000158	0.000967	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Cyclosporine—psoriasis	0.000157	0.000966	CcSEcCtD
Aminosalicylic Acid—Malnutrition—Methotrexate—psoriasis	0.000156	0.000956	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Prednisolone—psoriasis	0.000154	0.000946	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000154	0.000942	CcSEcCtD
Aminosalicylic Acid—Urticaria—Triamcinolone—psoriasis	0.000153	0.000938	CcSEcCtD
Aminosalicylic Acid—Dysgeusia—Methotrexate—psoriasis	0.000153	0.000936	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Triamcinolone—psoriasis	0.000152	0.000934	CcSEcCtD
Aminosalicylic Acid—Dizziness—Cyclosporine—psoriasis	0.000152	0.000933	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Betamethasone—psoriasis	0.000152	0.000932	CcSEcCtD
Aminosalicylic Acid—Decreased appetite—Dexamethasone—psoriasis	0.000152	0.000932	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000151	0.000925	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal disorder—Betamethasone—psoriasis	0.000151	0.000925	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Hydrocortisone—psoriasis	0.000151	0.000924	CcSEcCtD
Aminosalicylic Acid—Nervous system disorder—Prednisone—psoriasis	0.000149	0.000915	CcSEcCtD
Aminosalicylic Acid—Dizziness—Mycophenolate mofetil—psoriasis	0.000148	0.000911	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Prednisone—psoriasis	0.000148	0.000907	CcSEcCtD
Aminosalicylic Acid—Vomiting—Cyclosporine—psoriasis	0.000146	0.000897	CcSEcCtD
Aminosalicylic Acid—Rash—Cyclosporine—psoriasis	0.000145	0.00089	CcSEcCtD
Aminosalicylic Acid—Anorexia—Prednisone—psoriasis	0.000145	0.00089	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Cyclosporine—psoriasis	0.000145	0.000889	CcSEcCtD
Aminosalicylic Acid—Headache—Cyclosporine—psoriasis	0.000144	0.000884	CcSEcCtD
Aminosalicylic Acid—Anaemia—Methotrexate—psoriasis	0.000144	0.000883	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Betamethasone—psoriasis	0.000143	0.000876	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Dexamethasone—psoriasis	0.000143	0.000876	CcSEcCtD
Aminosalicylic Acid—Vomiting—Mycophenolate mofetil—psoriasis	0.000143	0.000875	CcSEcCtD
Aminosalicylic Acid—Hypersensitivity—Triamcinolone—psoriasis	0.000142	0.00087	CcSEcCtD
Aminosalicylic Acid—Rash—Mycophenolate mofetil—psoriasis	0.000142	0.000868	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Mycophenolate mofetil—psoriasis	0.000141	0.000867	CcSEcCtD
Aminosalicylic Acid—Headache—Mycophenolate mofetil—psoriasis	0.000141	0.000863	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Hydrocortisone—psoriasis	0.00014	0.000858	CcSEcCtD
Aminosalicylic Acid—Leukopenia—Methotrexate—psoriasis	0.000139	0.000856	CcSEcCtD
Aminosalicylic Acid—Urticaria—Dexamethasone—psoriasis	0.000139	0.000851	CcSEcCtD
Aminosalicylic Acid—Urticaria—Betamethasone—psoriasis	0.000139	0.000851	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisolone—psoriasis	0.000138	0.000849	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Betamethasone—psoriasis	0.000138	0.000847	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Betamethasone—psoriasis	0.000138	0.000847	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Dexamethasone—psoriasis	0.000138	0.000847	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Dexamethasone—psoriasis	0.000138	0.000847	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—NFKB1—psoriasis	0.000138	0.000974	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Cyclosporine—psoriasis	0.000137	0.000838	CcSEcCtD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—psoriasis	0.000136	0.000959	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—psoriasis	0.000135	0.000957	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—NFKB1—psoriasis	0.000135	0.000957	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Hydrocortisone—psoriasis	0.000135	0.00083	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—JUN—psoriasis	0.000135	0.000953	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Mycophenolate mofetil—psoriasis	0.000133	0.000818	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism—CAT—psoriasis	0.000133	0.000943	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—NFKB1—psoriasis	0.000133	0.000941	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—JUN—psoriasis	0.000133	0.000938	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Prednisone—psoriasis	0.000132	0.000811	CcSEcCtD
Aminosalicylic Acid—Rash—Prednisolone—psoriasis	0.000132	0.00081	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisolone—psoriasis	0.000132	0.000809	CcSEcCtD
Aminosalicylic Acid—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000132	0.000808	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NFKBIA—psoriasis	0.000132	0.000931	CbGpPWpGaD
Aminosalicylic Acid—Headache—Prednisolone—psoriasis	0.000131	0.000805	CcSEcCtD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—ICAM1—psoriasis	0.000131	0.000928	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—STAT3—psoriasis	0.000131	0.000925	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL4—psoriasis	0.000131	0.000924	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Hydrocortisone—psoriasis	0.00013	0.000798	CcSEcCtD
Aminosalicylic Acid—CHUK—B Cell Receptor Signaling Pathway—NFKB1—psoriasis	0.00013	0.000918	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—JUN—psoriasis	0.000129	0.000916	CbGpPWpGaD
Aminosalicylic Acid—Rash—Hydrocortisone—psoriasis	0.000129	0.000791	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Hydrocortisone—psoriasis	0.000129	0.00079	CcSEcCtD
Aminosalicylic Acid—Headache—Hydrocortisone—psoriasis	0.000128	0.000786	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—NFKB1—psoriasis	0.000128	0.000903	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Triamcinolone—psoriasis	0.000127	0.000781	CcSEcCtD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	0.000127	0.000896	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—SOCS1—psoriasis	0.000127	0.000895	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	0.000126	0.000889	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NFKBIA—psoriasis	0.000126	0.000889	CbGpPWpGaD
Aminosalicylic Acid—Nervous system disorder—Methotrexate—psoriasis	0.000125	0.000765	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—NFKB1—psoriasis	0.000125	0.000881	CbGpPWpGaD
Aminosalicylic Acid—Thrombocytopenia—Methotrexate—psoriasis	0.000125	0.000764	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Prednisone—psoriasis	0.000124	0.000763	CcSEcCtD
Aminosalicylic Acid—Nausea—Prednisolone—psoriasis	0.000124	0.000763	CcSEcCtD
Aminosalicylic Acid—Skin disorder—Methotrexate—psoriasis	0.000124	0.000758	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—TYK2—psoriasis	0.000123	0.000873	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—TYK2—psoriasis	0.000123	0.000873	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Triamcinolone—psoriasis	0.000122	0.000751	CcSEcCtD
Aminosalicylic Acid—Nausea—Hydrocortisone—psoriasis	0.000121	0.000745	CcSEcCtD
Aminosalicylic Acid—Rash—Triamcinolone—psoriasis	0.000121	0.000745	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Triamcinolone—psoriasis	0.000121	0.000744	CcSEcCtD
Aminosalicylic Acid—Anorexia—Methotrexate—psoriasis	0.000121	0.000744	CcSEcCtD
Aminosalicylic Acid—Urticaria—Prednisone—psoriasis	0.000121	0.000741	CcSEcCtD
Aminosalicylic Acid—Headache—Triamcinolone—psoriasis	0.000121	0.00074	CcSEcCtD
Aminosalicylic Acid—Abdominal pain—Prednisone—psoriasis	0.00012	0.000738	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Prednisone—psoriasis	0.00012	0.000738	CcSEcCtD
Aminosalicylic Acid—CHUK—Rac1/Pak1/p38/MMP-2 pathway—TP53—psoriasis	0.00012	0.000846	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Betamethasone—psoriasis	0.00012	0.000733	CcSEcCtD
Aminosalicylic Acid—Diarrhoea—Dexamethasone—psoriasis	0.00012	0.000733	CcSEcCtD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—JUN—psoriasis	0.000119	0.000844	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—psoriasis	0.000119	0.000842	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—NFKB1—psoriasis	0.000119	0.000842	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.000118	0.000836	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—TYK2—psoriasis	0.000118	0.000835	CbGpPWpGaD
Aminosalicylic Acid—CHUK—p75(NTR)-mediated signaling—TP53—psoriasis	0.000117	0.000826	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NFKBIA—psoriasis	0.000116	0.000822	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—TYK2—psoriasis	0.000116	0.000822	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Dexamethasone—psoriasis	0.000116	0.000709	CcSEcCtD
Aminosalicylic Acid—Dizziness—Betamethasone—psoriasis	0.000116	0.000709	CcSEcCtD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—NFKB1—psoriasis	0.000115	0.000812	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Triamcinolone—psoriasis	0.000114	0.000702	CcSEcCtD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ITGAL—psoriasis	0.000114	0.000808	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TNF—psoriasis	0.000113	0.000801	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—psoriasis	0.000113	0.000801	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—JUN—psoriasis	0.000112	0.000793	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Prednisone—psoriasis	0.000112	0.000688	CcSEcCtD
Aminosalicylic Acid—Vomiting—Betamethasone—psoriasis	0.000111	0.000681	CcSEcCtD
Aminosalicylic Acid—Vomiting—Dexamethasone—psoriasis	0.000111	0.000681	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signal transduction—TYK2—psoriasis	0.000111	0.000785	CbGpPWpGaD
Aminosalicylic Acid—Decreased appetite—Methotrexate—psoriasis	0.000111	0.000678	CcSEcCtD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—LEP—psoriasis	0.00011	0.000781	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—TYK2—psoriasis	0.00011	0.000781	CbGpPWpGaD
Aminosalicylic Acid—Rash—Dexamethasone—psoriasis	0.00011	0.000676	CcSEcCtD
Aminosalicylic Acid—Rash—Betamethasone—psoriasis	0.00011	0.000676	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Dexamethasone—psoriasis	0.00011	0.000675	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Betamethasone—psoriasis	0.00011	0.000675	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—TYK2—psoriasis	0.00011	0.000777	CbGpPWpGaD
Aminosalicylic Acid—Gastrointestinal disorder—Methotrexate—psoriasis	0.00011	0.000673	CcSEcCtD
Aminosalicylic Acid—Headache—Betamethasone—psoriasis	0.000109	0.000671	CcSEcCtD
Aminosalicylic Acid—Headache—Dexamethasone—psoriasis	0.000109	0.000671	CcSEcCtD
Aminosalicylic Acid—CHUK—DAP12 signaling—TYK2—psoriasis	0.000109	0.000774	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—CXCL8—psoriasis	0.000109	0.000769	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000109	0.000768	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IFIH1—psoriasis	0.000108	0.000764	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-B—psoriasis	0.000108	0.000764	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—psoriasis	0.000108	0.000764	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—STAT3—psoriasis	0.000107	0.000757	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—REL—psoriasis	0.000107	0.000756	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—TNF—psoriasis	0.000105	0.000745	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	0.000105	0.00074	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Prednisone—psoriasis	0.000104	0.000639	CcSEcCtD
Aminosalicylic Acid—Gastrointestinal pain—Methotrexate—psoriasis	0.000104	0.000638	CcSEcCtD
Aminosalicylic Acid—CHUK—Immune System—ERAP1—psoriasis	0.000104	0.000735	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Betamethasone—psoriasis	0.000104	0.000637	CcSEcCtD
Aminosalicylic Acid—Nausea—Dexamethasone—psoriasis	0.000104	0.000637	CcSEcCtD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—ICAM1—psoriasis	0.000104	0.000734	CbGpPWpGaD
Aminosalicylic Acid—PLA2G2E—Metabolism—APOE—psoriasis	0.000104	0.000733	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—NOS2—psoriasis	0.000103	0.000728	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—TYK2—psoriasis	0.000103	0.000728	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—TYK2—psoriasis	0.000103	0.000728	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—TYK2—psoriasis	0.000103	0.000728	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-C—psoriasis	0.000102	0.000724	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—TYK2—psoriasis	0.000102	0.000721	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—psoriasis	0.000102	0.000718	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TNFAIP3—psoriasis	0.000101	0.000716	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—TYK2—psoriasis	0.000101	0.000715	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—JUN—psoriasis	0.000101	0.000715	CbGpPWpGaD
Aminosalicylic Acid—Urticaria—Methotrexate—psoriasis	0.000101	0.00062	CcSEcCtD
Aminosalicylic Acid—Dizziness—Prednisone—psoriasis	0.000101	0.000617	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling by PDGF—TYK2—psoriasis	0.000101	0.000712	CbGpPWpGaD
Aminosalicylic Acid—Abdominal pain—Methotrexate—psoriasis	0.000101	0.000617	CcSEcCtD
Aminosalicylic Acid—Body temperature increased—Methotrexate—psoriasis	0.000101	0.000617	CcSEcCtD
Aminosalicylic Acid—PTGS2—C-MYB transcription factor network—CD4—psoriasis	0.0001	0.000708	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-A—psoriasis	0.0001	0.000708	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—psoriasis	0.0001	0.000708	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—JUN—psoriasis	9.99e-05	0.000707	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IFNG—psoriasis	9.98e-05	0.000706	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Apoptosis—TP53—psoriasis	9.98e-05	0.000706	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-C—psoriasis	9.83e-05	0.000696	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—JUN—psoriasis	9.82e-05	0.000695	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—NFKB1—psoriasis	9.73e-05	0.000688	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—TNF—psoriasis	9.69e-05	0.000686	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Prednisone—psoriasis	9.68e-05	0.000593	CcSEcCtD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—NFKB1—psoriasis	9.62e-05	0.00068	CbGpPWpGaD
Aminosalicylic Acid—Rash—Prednisone—psoriasis	9.59e-05	0.000589	CcSEcCtD
Aminosalicylic Acid—Dermatitis—Prednisone—psoriasis	9.59e-05	0.000588	CcSEcCtD
Aminosalicylic Acid—Headache—Prednisone—psoriasis	9.53e-05	0.000585	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—JUN—psoriasis	9.46e-05	0.000669	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—NFKB1—psoriasis	9.45e-05	0.000669	CbGpPWpGaD
Aminosalicylic Acid—Hypersensitivity—Methotrexate—psoriasis	9.37e-05	0.000575	CcSEcCtD
Aminosalicylic Acid—CHUK—Signaling Pathways—HCAR2—psoriasis	9.34e-05	0.000661	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—DDX58—psoriasis	9.14e-05	0.000647	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—HLA-DRB1—psoriasis	9.14e-05	0.000647	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.11e-05	0.000645	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	9.11e-05	0.000645	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—NFKB1—psoriasis	9.1e-05	0.000644	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 cascade initiated on plasma membrane—IL6—psoriasis	9.05e-05	0.00064	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Prednisone—psoriasis	9.04e-05	0.000554	CcSEcCtD
Aminosalicylic Acid—PLA2G2E—Metabolism—PPARG—psoriasis	9.02e-05	0.000638	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—psoriasis	8.96e-05	0.000634	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—NDUFA5—psoriasis	8.87e-05	0.000627	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88 dependent cascade initiated on endosome—IL6—psoriasis	8.8e-05	0.000623	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—ICAM1—psoriasis	8.77e-05	0.000621	CbGpPWpGaD
Aminosalicylic Acid—Diarrhoea—Methotrexate—psoriasis	8.7e-05	0.000534	CcSEcCtD
Aminosalicylic Acid—CHUK—TCR Signaling Pathway—IL6—psoriasis	8.64e-05	0.000612	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—STAT3—psoriasis	8.64e-05	0.000611	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NFKBIA—psoriasis	8.56e-05	0.000605	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-E—psoriasis	8.5e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—CHUK—BDNF signaling pathway—STAT3—psoriasis	8.5e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—CHUK—TNF alpha Signaling Pathway—IL6—psoriasis	8.49e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 9 (TLR9) Cascade—IL6—psoriasis	8.49e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CARM1—psoriasis	8.49e-05	0.000601	CbGpPWpGaD
Aminosalicylic Acid—Dizziness—Methotrexate—psoriasis	8.41e-05	0.000516	CcSEcCtD
Aminosalicylic Acid—CHUK—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—psoriasis	8.4e-05	0.000594	CbGpPWpGaD
Aminosalicylic Acid—CHUK—MyD88:Mal cascade initiated on plasma membrane—IL6—psoriasis	8.35e-05	0.000591	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	8.33e-05	0.00059	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—JUN—psoriasis	8.33e-05	0.000589	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—NFKB1—psoriasis	8.3e-05	0.000588	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.27e-05	0.000585	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—VEGFA—psoriasis	8.26e-05	0.000584	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-E—psoriasis	8.16e-05	0.000577	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	8.14e-05	0.000576	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TAGAP—psoriasis	8.1e-05	0.000573	CbGpPWpGaD
Aminosalicylic Acid—Vomiting—Methotrexate—psoriasis	8.09e-05	0.000496	CcSEcCtD
Aminosalicylic Acid—Rash—Methotrexate—psoriasis	8.02e-05	0.000492	CcSEcCtD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—NFKB1—psoriasis	8.02e-05	0.000567	CbGpPWpGaD
Aminosalicylic Acid—Dermatitis—Methotrexate—psoriasis	8.01e-05	0.000491	CcSEcCtD
Aminosalicylic Acid—CHUK—MyD88-independent cascade—IL6—psoriasis	8.01e-05	0.000567	CbGpPWpGaD
Aminosalicylic Acid—Headache—Methotrexate—psoriasis	7.97e-05	0.000489	CcSEcCtD
Aminosalicylic Acid—ALOX5—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.94e-05	0.000562	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IFNG—psoriasis	7.89e-05	0.000558	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	7.84e-05	0.000554	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-like Receptor Signaling Pathway—IL6—psoriasis	7.82e-05	0.000553	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—STAT3—psoriasis	7.77e-05	0.00055	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—TNF—psoriasis	7.57e-05	0.000535	CbGpPWpGaD
Aminosalicylic Acid—Nausea—Methotrexate—psoriasis	7.55e-05	0.000463	CcSEcCtD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.54e-05	0.000534	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CYP2S1—psoriasis	7.54e-05	0.000533	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by Interleukins—IL6—psoriasis	7.47e-05	0.000529	CbGpPWpGaD
Aminosalicylic Acid—CHUK—B Cell Activation—NFKB1—psoriasis	7.42e-05	0.000525	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—CXCL8—psoriasis	7.34e-05	0.000519	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Activated TLR4 signalling—IL6—psoriasis	7.21e-05	0.00051	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—STAT3—psoriasis	7.2e-05	0.00051	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—TYK2—psoriasis	7.13e-05	0.000504	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—SOCS1—psoriasis	7.1e-05	0.000502	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—STAT3—psoriasis	7.04e-05	0.000498	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—NDUFA5—psoriasis	7.04e-05	0.000498	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—TYK2—psoriasis	7.01e-05	0.000496	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	7e-05	0.000495	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ITGAL—psoriasis	6.93e-05	0.00049	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6.85e-05	0.000484	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—SOCS1—psoriasis	6.81e-05	0.000482	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll Like Receptor 4 (TLR4) Cascade—IL6—psoriasis	6.78e-05	0.000479	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IFNG—psoriasis	6.67e-05	0.000472	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	6.57e-05	0.000465	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.56e-05	0.000464	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—REL—psoriasis	6.48e-05	0.000458	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—TNF—psoriasis	6.46e-05	0.000457	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	6.38e-05	0.000451	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFIH1—psoriasis	6.29e-05	0.000445	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Breast Cancer Pathway—TP53—psoriasis	6.24e-05	0.000442	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Regulation of toll-like receptor signaling pathway—IL6—psoriasis	6.11e-05	0.000432	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—HLA-B—psoriasis	6.05e-05	0.000428	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD8A—psoriasis	6.04e-05	0.000428	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by SCF-KIT—IL6—psoriasis	6.04e-05	0.000427	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Toll-Like Receptors Cascades—IL6—psoriasis	6.04e-05	0.000427	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CYP2S1—psoriasis	5.99e-05	0.000424	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-C—psoriasis	5.96e-05	0.000422	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TNFAIP3—psoriasis	5.89e-05	0.000417	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.87e-05	0.000415	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-B—psoriasis	5.81e-05	0.000411	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signaling of activated FGFR—IL6—psoriasis	5.78e-05	0.000409	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB4—IL6—psoriasis	5.68e-05	0.000402	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—NFKB1—psoriasis	5.55e-05	0.000393	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—NFKB1—psoriasis	5.46e-05	0.000386	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Downstream signal transduction—IL6—psoriasis	5.43e-05	0.000384	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR—IL6—psoriasis	5.4e-05	0.000382	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-A—psoriasis	5.39e-05	0.000381	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by ERBB2—IL6—psoriasis	5.37e-05	0.00038	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CRP—psoriasis	5.35e-05	0.000379	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 signaling—IL6—psoriasis	5.35e-05	0.000378	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—CAT—psoriasis	5.22e-05	0.00037	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Selenium Micronutrient Network—IL6—psoriasis	5.21e-05	0.000369	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.17e-05	0.000366	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TNF—psoriasis	5.11e-05	0.000361	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Fc epsilon receptor (FCERI) signaling—IL6—psoriasis	5.03e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—DAP12 interactions—IL6—psoriasis	5.03e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by FGFR in disease—IL6—psoriasis	5.03e-05	0.000356	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—STAT3—psoriasis	4.99e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR—IL6—psoriasis	4.99e-05	0.000353	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-E—psoriasis	4.95e-05	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by EGFR in Cancer—IL6—psoriasis	4.94e-05	0.00035	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—HLA-DRB1—psoriasis	4.92e-05	0.000348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by PDGF—IL6—psoriasis	4.92e-05	0.000348	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—STAT3—psoriasis	4.91e-05	0.000347	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKBIA—psoriasis	4.88e-05	0.000345	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CCL20—psoriasis	4.85e-05	0.000343	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—ICAM1—psoriasis	4.72e-05	0.000334	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKBIA—psoriasis	4.69e-05	0.000332	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	4.64e-05	0.000328	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—TP53—psoriasis	4.5e-05	0.000319	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	4.47e-05	0.000316	CbGpPWpGaD
Aminosalicylic Acid—CHUK—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	4.46e-05	0.000315	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—SOCS1—psoriasis	4.13e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Spinal Cord Injury—IL6—psoriasis	4.12e-05	0.000292	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—APOE—psoriasis	4.06e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.05e-05	0.000287	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—TYK2—psoriasis	4e-05	0.000283	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.95e-05	0.00028	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CARM1—psoriasis	3.68e-05	0.000261	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD8A—psoriasis	3.67e-05	0.000259	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—CD4—psoriasis	3.62e-05	0.000256	CbGpPWpGaD
Aminosalicylic Acid—ALOX5—Metabolism—PPARG—psoriasis	3.54e-05	0.00025	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-B—psoriasis	3.53e-05	0.000249	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Cytokine Signaling in Immune system—IL6—psoriasis	3.49e-05	0.000247	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	3.48e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—CD4—psoriasis	3.47e-05	0.000246	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.44e-05	0.000244	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling by NGF—IL6—psoriasis	3.43e-05	0.000243	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-A—psoriasis	3.27e-05	0.000231	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—JUN—psoriasis	3.24e-05	0.000229	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.14e-05	0.000222	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CRP—psoriasis	3.12e-05	0.000221	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—NFKB1—psoriasis	3.11e-05	0.00022	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.06e-05	0.000217	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—HLA-A—psoriasis	3.02e-05	0.000213	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Adaptive Immune System—NFKB1—psoriasis	2.99e-05	0.000212	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—HLA-DRB1—psoriasis	2.99e-05	0.000211	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CARM1—psoriasis	2.92e-05	0.000207	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—ICAM1—psoriasis	2.87e-05	0.000203	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKBIA—psoriasis	2.84e-05	0.000201	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—APOE—psoriasis	2.82e-05	0.000199	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.73e-05	0.000193	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—SOCS1—psoriasis	2.67e-05	0.000189	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—NOS2—psoriasis	2.62e-05	0.000186	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—TYK2—psoriasis	2.33e-05	0.000165	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—CAT—psoriasis	2.27e-05	0.00016	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IFNG—psoriasis	2.18e-05	0.000154	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—TYK2—psoriasis	2.15e-05	0.000152	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—CD4—psoriasis	2.11e-05	0.000149	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—LEP—psoriasis	1.97e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—APOE—psoriasis	1.97e-05	0.00014	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Innate Immune System—IL6—psoriasis	1.96e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—CD4—psoriasis	1.94e-05	0.000138	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—JUN—psoriasis	1.88e-05	0.000133	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKBIA—psoriasis	1.84e-05	0.00013	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—NFKB1—psoriasis	1.81e-05	0.000128	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—CAT—psoriasis	1.8e-05	0.000127	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—HLA-A—psoriasis	1.79e-05	0.000126	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—APOE—psoriasis	1.76e-05	0.000125	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—APOE—psoriasis	1.67e-05	0.000118	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—STAT3—psoriasis	1.63e-05	0.000115	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—NOS2—psoriasis	1.55e-05	0.00011	CbGpPWpGaD
Aminosalicylic Acid—PTGS1—Metabolism—PPARG—psoriasis	1.53e-05	0.000108	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TYK2—psoriasis	1.51e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—STAT3—psoriasis	1.51e-05	0.000106	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—APOE—psoriasis	1.4e-05	9.88e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—CXCL8—psoriasis	1.31e-05	9.27e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—TYK2—psoriasis	1.27e-05	9.01e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—JUN—psoriasis	1.22e-05	8.62e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Metabolism—PPARG—psoriasis	1.22e-05	8.61e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—NFKB1—psoriasis	1.17e-05	8.3e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—CD4—psoriasis	1.15e-05	8.15e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Immune System—IL6—psoriasis	1.14e-05	8.06e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—VEGFA—psoriasis	1.06e-05	7.53e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—STAT3—psoriasis	1.05e-05	7.46e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Disease—IL6—psoriasis	1.05e-05	7.44e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—STAT3—psoriasis	8.92e-06	6.31e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—TP53—psoriasis	8.04e-06	5.69e-05	CbGpPWpGaD
Aminosalicylic Acid—CHUK—Signaling Pathways—IL6—psoriasis	7.36e-06	5.21e-05	CbGpPWpGaD
Aminosalicylic Acid—PTGS2—Disease—IL6—psoriasis	6.23e-06	4.41e-05	CbGpPWpGaD
